Načítá se...
Target class drug discovery
Selection of molecular targets based on disease understanding is a dominant paradigm in drug discovery. We argue that a focus on classes of targets with central roles in biology provides a complementary approach that has higher quality outcomes in early discovery efforts.
Uloženo v:
| Vydáno v: | Nat Chem Biol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5973815/ https://ncbi.nlm.nih.gov/pubmed/28926557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nchembio.2473 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|